Facebook Instagram Linkedin Youtube
Home Tags MAGNUS essand

Tag: MAGNUS essand

Janssen CAR T deal supports Elicera’s vision

Janssen CAR T deal supports Elicera’s vision

Elicera Q4 2022

Advancements for Elicera in 2022 open for intensive clinical year

CAR T therapy revolution cancer

The CAR T revolution in the fight against cancer

Elicera strong financial

Elicera Therapeutics strengthens financial standing in Q2

Funding

Elicera receives funding for clinical trials with ELC-301

ELICERA's CSO and Co-founder MAGNUS ESSAND

BioStock Studio: Elicera’s immuno-oncology platform iTANK reaches high-impact journal

Elicera Therapeutics takes immuno-oncology to the next level

© BioStock 2024